Despite a weak year for smallcaps, 15 stocks delivered multibagger returns in 2025. Cupid led the pack with a 440% surge, far outperforming peers such as Indo Thai Securities and Kothari Industrial Corporation. The gains stood out even as the BSE Smallcap index lagged midcaps and largecaps.Read More

Bitcoin hovered near the $87,000 mark despite ETF outflows exceeding $350 million, reflecting cautious but resilient investor sentiment. Analysts note steady accumulation by large holders, low exchange reserves and mixed macro cues, suggesting consolidation with upside potential toward $90,000 if momentum sustains.Read More

Motilal Oswal has initiated coverage on Astra Microwave Products with a Buy rating and a target price of Rs 1,100, citing its transition to a full systems player, strong order visibility, expanding defence opportunities and improving margins.Read More

Jefferies has reiterated its Buy rating on Eternal with a target price of Rs 480, citing strong growth prospects, improving unit economics and limited impact from Swiggy’s fundraising and Zepto’s potential IPO on competitive dynamics.Read More

Japan’s 10-year government bond yield surged to an 18-year peak of 1.980% on Wednesday, fueled by concerns over the government’s record-breaking draft budget for fiscal 2026, which is projected to exceed 120 trillion yen. This fiscal worry, coupled with expectations of Bank of Japan rate hikes, prompted investors to sell longer-dated bonds, pushing yields higher...Read More

With markets under pressure in December, experts say it is a stock-picker’s phase. ETMarkets highlights five brokerage-recommended stocks offering potential upside of up to 22%.Read More

India’s Insurance Act Amendment Bill, ‘Sabka Bima Sabki Raksha,’ aims for a structural overhaul of the insurance sector, including amendments to the LIC Act. The bill’s omission of open architecture for individual agents is seen as a relief for LIC, which relies heavily on its agent network.Read More

The Indian rupee experienced a significant rebound on Wednesday, climbing 0.7% after hitting record lows for four straight days. This surge followed aggressive intervention by the Reserve Bank of India, with state-run banks reportedly selling dollars. The currency’s earlier decline was attributed to portfolio outflows and ongoing trade tensions with the United States.Read More

Nephrocare Health Services debuted on stock exchanges with a 7% premium, opening at Rs 491.70 on BSE and Rs 490 on NSE. The company’s Rs 871.39 crore IPO saw robust demand, with QIBs and NIIs leading subscriptions. Nephrocare, India’s largest dialysis provider, aims to use IPO proceeds for debt reduction and expansion.Read More

Park Medi World debuted on the stock market, listing at a discount of up to 4% despite strong IPO demand. The IPO saw an overall subscription of 8.52 times, with non-institutional investors leading the charge. The NII portion was subscribed nearly 16 times. The hospital chain’s shares opened below grey market expectations, reflecting cautious investor...Read More